Quanta Dialysis Technologies

Quanta has developed an advanced haemodialysis system for use in the
home and clinic. Our proprietary  cartridge-based system, SC+, is a
portable and compact providing clinical efficacy utilising high flow
rates typically used on traditional machines. SC+ is designed to offer
ease-of-use and flexibility, facilitating self-care and supporting
dialysis patients across the entire continuum of care.

Quanta is privately owned and based in Alcester, UK. The Company was
founded in 2008 as a spin out from the FTSE 100 engineering company IMI
plc, with funding provided by a group of leading venture capital
investors specialised in healthcare: Air Liquide, b-to-v Partners AG,
IMI, Kuwait Life Sciences Company, NBGI Ventures, Seroba Kernel
LifeSciences, Seventure Partners and Wellington Partners.

Type
Private
HQ
Warwickshire, GB
Founded
2008
Employees
70 (est)+3%

Quanta Dialysis Technologies Locations

Warwickshire, GB

Quanta Dialysis Technologies Metrics

Quanta Dialysis Technologies Summary

Founding Date

2008

Total Funding

$57.5 M

Latest funding size

$2.89 M

Time since last funding

over 1 year

Investors

Quanta Dialysis Technologies Financials

FY, 2013

Revenue

£453 K

Quanta Dialysis Technologies Online Presence

Quanta Dialysis Technologies News

Quanta Dialysis Technologies Company Life

You may also be interested in